Sci-tech

Here's The Launch Trailer, PC Features For 'The Evil Within 2'

Here's The Launch Trailer, PC Features For 'The Evil Within 2'”

With The Evil Within 2 set to release in just a couple of days, Bethesda has sent out a brand new trailer for the game to scare us into excitement. Check out the twisted launch trailer below, and be sure to check back shortly after launch for THDR's full review of The Evil Within 2.

The Evil Within 2 is almost upon us and to wet our beaks just a bit more before Friday, Bethesda Softworks released a new launch trailer for the third-person horror title earlier this morning. Locked in STEM, a system that allows multiple people to experience the dream-like worlds and memories, Castellanos must rescue his daughter before some of the baddies also in STEM cause it to fall apart.

You can check out the latest trailer below for The Evil Within 2 which will be coming to PlayStation 4, Xbox One and PC on Friday 13th October.

The only way out... is in.

Players once again get to put themselves in the shoes of Sebastian Castellanos to confront the horrors of the STEM machine.

That little girl is key to the story of The Evil Within 2 and Sebastian's overall goal.

Are you ready to return to the nightmare? This time he has a personal mission which is to find and save his daughter who he thought had died many years ago. Or will they both perish and forever be lost in STEM?



Like this

Latest


12 October 2017
Daiwa Securities Group Inc. Grows Position in Oracle Corporation (ORCL)
Oracle Corporation accounts for 2.5% of Tufton Capital Management's portfolio, making the stock its 5th largest position. BidaskClub cut Oracle Corporation from a "buy" rating to a "hold" rating in a research report on Wednesday, June 14th.

12 October 2017
First Data Corporation (FDC) has a market cap of $16.41 Billion
The lowest price target is presently $N/A and the analyst with the most aggressive opinion sees the stock going to $N/A. The Return on Equity (ROE) and Return on Investment (ROI) values are 41.5 percent and 7.4 percent respectively.

12 October 2017
Twitter reverses decision to block candidate's Senate video
Blackburn's now-permitted advertising, so there's no longer a rational basis for it to ban Live Action's ads. Twitter's censorship in favor of Planned Parenthood or abortion did not start with the Blackburn campaign.

12 October 2017
Harvey Weinstein denies rape accusations
But in the statement last week, Weinstein said he would name the endowment after his mother, adding, "I won't disappoint her". Weinstein's spokeswoman Sallie Hofmeister issued a statement in response to the allegations in the article.

12 October 2017
Gotham Asset Management LLC Buys 20039 Shares of Northrop Grumman Corporation (NOC)
The stock of Northrop Grumman Corporation (NYSE:NOC) has "Outperform" rating given on Thursday, January 12 by RBC Capital Markets. The aerospace company reported $3.63 earnings per share for the quarter, beating analysts' consensus estimates of $2.90 by $0.73.

12 October 2017
Piyush central minister, not CA: Sinha
He said it was an issue of national importance as the turnover of Mr Jay Shah's company had increased substantially during the BJP rule.

12 October 2017
New deal for Chambers
Calum Chambers signs a new two-year contract extension at Arsenal until 2021. I'm going to repay the fans for the faith they've shown in me.

11 October 2017
Panama ballboy becomes global hero after hilarious intervention in World Cup game
No doubt he should be given a ticking-off for something so unsporting, but Panama's football authorities could be forgiven for turning a blind eye after their historic achievement.

11 October 2017
'American Horror Story: Cult' episode edited after Las Vegas shooting
Now in its seventh season, " American Horror Story " regularly lives up to its name with ghoulish and violent displays. The unedited episode can be viewed on digital platforms FXNOW and FX+, along with VOD platforms.

11 October 2017
Morning Watch List Corcept Therapeutics Incorporated (NASDAQ:CORT)
The stock of Corcept Therapeutics Incorporated (NASDAQ: CORT ) has "Buy" rating given on Friday, September 8 by Piper Jaffray. Investors are more bearish on shares of Corcept Therapeutics Incorporat lately as evidenced by the motion in short interest.



Recommended